This article was originally published in The Rose Sheet
Reliant Technologies, Inc., "the pioneer of fractional resurfacing and market leader of aesthetic laser skin treatments," announced its distinction as nation's 157 fastest growing company out of 500 companies by Inc. magazine, according to August 21 release. Inc. magazine also named Reliant fifth in top 50 businesses in Silicon Valley and eighth among top U.S. health companies. In 2004, Reliant Technologies introduced Fraxel platform of lasers, "the most advanced skin resurfacing systems available for dermatologists and cosmetic surgeons," says release. Sales of Fraxel laser systems contributed to company's $70.5 million revenue in 2007, a 1,450 percent increase since 2004. Eric Stang, CEO and president of Reliant Technologies, says that Fraxel brand has become "the gold standard in laser skin resurfacing preferred by physicians and patients alike." The firm recently announced a partnership with electronics giant Philips to develop laser skin-rejuvenation technology for at-home use (1"The Rose Sheet" August 18, 2008, p. 5)
You may also be interested in...
Reliant Technologies Inc., developer of Fraxel laser systems, has partnered with electronics giant Philips to develop laser skin-rejuvenation technology for use at home, taking a cue from some of the industry's biggest players that are making moves toward the aesthetic devices market
The Italian firm's move to license Isturisa from Novartis last year is paying dividends already and Recordati has already tripled its peak sales forecast for the Cushing's therapy.
Pfizer is up against AstraZeneca and Sanofi in developing competing approaches to tackling the unmet need in respiratory syncytial virus (RSV). But earlier failures mean all players will need much more data to sway regulators.